← Leaderboards
Jelena Levi
Cellsight Technologies, Inc.
$2,594,815
Attributed
$2,594,815
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2018–22$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,594,815 · 3
By mechanism
N44$1,995,174 · 1
N43$300,000 · 1
N01$299,641 · 1
Top collaborators
No co-investigators on record.
Most similar at Cellsight Technologies, Inc.
Same institution · by research overlap
- Samuel Ray Goth$1,020,489
Others in their field
Other Emerging Leaders on “Small Business Innovation Research Grant”
- Gary Fanger · Rise Therapeutics, Llc$23,463,293
- Molly Wasko · University Of Alabama At Birmingham$18,764,568
- Ashkan Vaziri · Biosensics, Llc$17,149,241
- Bryan L McLaughlin · Micro-Leads, Inc.$11,109,320
- Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
- Matthew Golden · Maphabit, Inc.$8,701,960
Research focus
Small Business Innovation Research GrantImmuneResponseT-LymphocytePositron-Emission TomographyCancer TherapyImmunotherapyImageChemotherapyTechnologyScanningTumorPatient SelectionCombination ImmunotherapyAnti-Pd-1Immunologic MonitoringImaging BiomarkerClinical ImagingCancer ImagingCellsBiological MarkersAntigen-Antibody ComplexImaging AgentImage Analysis
Grant awards (3)
SBIR PHASE II - TOPIC 396 - IMAGING FOR CANCER IMMUNOTHERAPIES$1,995,174
N44 · FY2022 · CA · contact PI
SBIR PHASE I TOPIC 396 EVALUATION OF [18F]F-ARAG, A T CELL-SPECIFIC PET AGENT, AS AN IMAGING BIOMARKER PREDICTIVE OF RESPONSE TO IMMUNOTHERAPIES - MOONSHOT$300,000
N43 · FY2019 · CA · contact PI
SBIR Topic 376: A noninvasive PET imaging strategy for longitudinal monitoring of immune contexture in the tumor microenvironment. Moonshot.$299,641
N01 · FY2018 · CA · contact PI